Phenotypic detection of clinical isolates of Haemophilus influenzae with altered penicillin-binding protein 3

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
A Aguirre-QuiñoneroL Martínez-Martínez

Abstract

The aims of this study were to determine the correlation of mutations in the ftsI gene (coding for PBP3) of Haemophilus influenzae with aminopenicillin resistance and to evaluate the 2017 European Committee for Antibiotic Susceptibility Testing (EUCAST) guidelines for clinical categorization of ampicillin, amoxicillin, and amoxicillin-clavulanate for strains with mutated PBP3 conferring resistance (rPBP3). A panel of 91 H. influenzae isolates was genetically characterized by sequencing of the fstI gene. For all the studied isolates, a screening with benzylpenicillin 1U (BP1) was carried out and minimum inhibitory concentrations (MICs) of ampicillin, amoxicillin, and amoxicillin-clavulanate were tested and interpreted according to EUCAST recommendations. ftsI sequence analysis revealed a total of 14 different amino acid substitutions in PBP3. The substitution patterns most commonly observed were [D350N, M377I, A502V, N526K] among the bla-positive rPBP3 strains (37.5%) and [D350N, A502T, N526K] among the bla-negative rPBP3 strains (24.5%). Screening with BP1 was able to correctly categorize 100% of the bla-negative sPBP3 strains, 100% of the bla-positive strains, and 92% of the bla-negative rPBP3 ones. Only 29% of the bla-negativ...Continue Reading

References

Apr 23, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Keiko HasegawaKimiko Ubukata
Feb 20, 2004·The Journal of Antimicrobial Chemotherapy·Pauliina KärpänojaHannu Sarkkinen
Apr 28, 2006·The Journal of Antimicrobial Chemotherapy·Stephen G Tristram, Scott Nichols
Aug 8, 2006·The Journal of Antimicrobial Chemotherapy·W T M JansenD Milatovic
Apr 13, 2007·Clinical Microbiology Reviews·Stephen TristramPeter C Appelbaum
Sep 10, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D SkaareB-E Kristiansen
May 17, 2011·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Niels Nørskov-LauritsenKurt Fuursted
Jul 19, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A CherkaouiJ Schrenzel
Sep 12, 2015·Journal of Clinical Microbiology·Dagfinn SkaareBjørn-Erik Kristiansen

❮ Previous
Next ❯

Citations

Jun 29, 2021·Journal of Applied Microbiology·Gieljam Johannes RoodeSharan Naidoo

❮ Previous
Next ❯

Datasets Mentioned

BETA
L42023

Software Mentioned

Sequencher

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.